The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma

Cancer Treat Rev. 1975 Sep;2(3):193-214. doi: 10.1016/s0305-7372(75)80003-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery
  • Adenocarcinoma / therapy*
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carmustine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / radiotherapy
  • Pancreatic Neoplasms / surgery
  • Pancreatic Neoplasms / therapy*
  • Prognosis
  • Radiotherapy Dosage

Substances

  • Antineoplastic Agents
  • Fluorouracil
  • Carmustine